Global Apheresis Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Apheresis Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Apheresis Market Size Growth Rate by Product
  • 1.4.2 Centrifugation
  • 1.4.3 Membrane Filtration
• 1.5 Market by End User
  • 1.5.1 Global Apheresis Market Size Growth Rate by End User
  • 1.5.2 Renal Diseases
  • 1.5.3 Neurology
  • 1.5.4 Cancer
  • 1.5.5 Hematology
  • 1.5.6 Autoimmune Diseases
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Apheresis Market Size
  • 2.1.1 Global Apheresis Revenue 2014-2025
  • 2.1.2 Global Apheresis Sales 2014-2025
• 2.2 Apheresis Growth Rate by Regions
  • 2.2.1 Global Apheresis Sales by Regions
  • 2.2.2 Global Apheresis Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Apheresis Sales by Manufacturers
  • 3.1.1 Apheresis Sales by Manufacturers
  • 3.1.2 Apheresis Sales Market Share by Manufacturers
  • 3.1.3 Global Apheresis Market Concentration Ratio (CR5 and HHI)
• 3.2 Apheresis Revenue by Manufacturers
  • 3.2.1 Apheresis Revenue by Manufacturers (2014-2019)
  • 3.2.2 Apheresis Revenue Share by Manufacturers (2014-2019)
• 3.3 Apheresis Price by Manufacturers
• 3.4 Apheresis Manufacturing Base Distribution, Product Types
  • 3.4.1 Apheresis Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Apheresis Product Type
  • 3.4.3 Date of International Manufacturers Enter into Apheresis Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Apheresis Sales by Product
• 4.2 Global Apheresis Revenue by Product
• 4.3 Apheresis Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Apheresis Breakdown Data by End User

6 North America

• 6.1 North America Apheresis by Countries
  • 6.1.1 North America Apheresis Sales by Countries
  • 6.1.2 North America Apheresis Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Apheresis by Product
• 6.3 North America Apheresis by End User

7 Europe

• 7.1 Europe Apheresis by Countries
  • 7.1.1 Europe Apheresis Sales by Countries
  • 7.1.2 Europe Apheresis Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Apheresis by Product
• 7.3 Europe Apheresis by End User

8 Asia Pacific

• 8.1 Asia Pacific Apheresis by Countries
  • 8.1.1 Asia Pacific Apheresis Sales by Countries
  • 8.1.2 Asia Pacific Apheresis Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Apheresis by Product
• 8.3 Asia Pacific Apheresis by End User

9 Central & South America

• 9.1 Central & South America Apheresis by Countries
  • 9.1.1 Central & South America Apheresis Sales by Countries
  • 9.1.2 Central & South America Apheresis Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Apheresis by Product
• 9.3 Central & South America Apheresis by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Apheresis by Countries
  • 10.1.1 Middle East and Africa Apheresis Sales by Countries
  • 10.1.2 Middle East and Africa Apheresis Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Apheresis by Product
• 10.3 Middle East and Africa Apheresis by End User

11 Company Profiles

• 11.1 Asahi Kasei Medical
  • 11.1.1 Asahi Kasei Medical Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Asahi Kasei Medical Apheresis Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Asahi Kasei Medical Apheresis Products Offered
  • 11.1.5 Asahi Kasei Medical Recent Development
• 11.2 Terumo Corporation
  • 11.2.1 Terumo Corporation Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Terumo Corporation Apheresis Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Terumo Corporation Apheresis Products Offered
  • 11.2.5 Terumo Corporation Recent Development
• 11.3 Haemonetics Corporation
  • 11.3.1 Haemonetics Corporation Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Haemonetics Corporation Apheresis Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Haemonetics Corporation Apheresis Products Offered
  • 11.3.5 Haemonetics Corporation Recent Development
• 11.4 Fresenius Kabi
  • 11.4.1 Fresenius Kabi Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 Fresenius Kabi Apheresis Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 Fresenius Kabi Apheresis Products Offered
  • 11.4.5 Fresenius Kabi Recent Development
• 11.5 Cerus Corporation
  • 11.5.1 Cerus Corporation Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Cerus Corporation Apheresis Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Cerus Corporation Apheresis Products Offered
  • 11.5.5 Cerus Corporation Recent Development
• 11.6 B. Braun Melsungen
  • 11.6.1 B. Braun Melsungen Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 B. Braun Melsungen Apheresis Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 B. Braun Melsungen Apheresis Products Offered
  • 11.6.5 B. Braun Melsungen Recent Development
• 11.7 Kawasumi Laboratories
  • 11.7.1 Kawasumi Laboratories Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Kawasumi Laboratories Apheresis Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Kawasumi Laboratories Apheresis Products Offered
  • 11.7.5 Kawasumi Laboratories Recent Development
• 11.8 NIKKISO
  • 11.8.1 NIKKISO Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 NIKKISO Apheresis Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 NIKKISO Apheresis Products Offered
  • 11.8.5 NIKKISO Recent Development
• 11.9 Therakos
  • 11.9.1 Therakos Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Therakos Apheresis Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Therakos Apheresis Products Offered
  • 11.9.5 Therakos Recent Development
• 11.10 Medica S.p.A
  • 11.10.1 Medica S.p.A Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Medica S.p.A Apheresis Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Medica S.p.A Apheresis Products Offered
  • 11.10.5 Medica S.p.A Recent Development

12 Future Forecast

• 12.1 Apheresis Market Forecast by Regions
  • 12.1.1 Global Apheresis Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Apheresis Revenue Forecast by Regions 2019-2025
• 12.2 Apheresis Market Forecast by Product
  • 12.2.1 Global Apheresis Sales Forecast by Product 2019-2025
  • 12.2.2 Global Apheresis Revenue Forecast by Product 2019-2025
• 12.3 Apheresis Market Forecast by End User
• 12.4 North America Apheresis Forecast
• 12.5 Europe Apheresis Forecast
• 12.6 Asia Pacific Apheresis Forecast
• 12.7 Central & South America Apheresis Forecast
• 12.8 Middle East and Africa Apheresis Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Apheresis Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details